107 related articles for article (PubMed ID: 3016453)
1. [Radiation doses to patients after the use of 99mTc-pyrophosphate and 113mIn-indifor].
Popov VI; Korsunskiĭ VN; Naumenko AZ; Koval'chuk ND
Med Radiol (Mosk); 1986 Jul; 31(7):53-7. PubMed ID: 3016453
[TBL] [Abstract][Full Text] [Related]
2. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of skeletal tumors using 113mIn-indifor].
Mechev DS; Siniuta BF
Med Radiol (Mosk); 1988 Jun; 33(6):22-7. PubMed ID: 2838715
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
5. [Radiation dose to the patient after administration of radioactive labelled colloids (author's transl)].
Wolf R; Hahn K
Rofo; 1975 Oct; 123(4):324-30. PubMed ID: 129390
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensional transport model for determining absorbed fractions of energy for electrons within trabecular bone.
Bouchet LG; Jokisch DW; Bolch WE
J Nucl Med; 1999 Nov; 40(11):1947-66. PubMed ID: 10565793
[TBL] [Abstract][Full Text] [Related]
7. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
[TBL] [Abstract][Full Text] [Related]
8. [Internal irradiation doses in patients during the diagnostic use of colloidal radiopharmaceutics].
Popov VI; Korsunskiĭ VN; Tarasenko IuI; Bogdanovich AI
Med Radiol (Mosk); 1989 Mar; 34(3):35-8. PubMed ID: 2927275
[TBL] [Abstract][Full Text] [Related]
9. Considerations of marrow cellularity in 3-dimensional dosimetric models of the trabecular skeleton.
Bolch WE; Patton PW; Rajon DA; Shah AP; Jokisch DW; Inglis BA
J Nucl Med; 2002 Jan; 43(1):97-108. PubMed ID: 11801712
[TBL] [Abstract][Full Text] [Related]
10. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. Task Group of the MIRD Committee, Society of Nuclear Medicine.
Thomas SR; Stabin MG; Chen CT; Samaratunga RC
J Nucl Med; 1999 Apr; 40(4):102S-123S. PubMed ID: 10210232
[TBL] [Abstract][Full Text] [Related]
11. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Konijnenberg MW; Bijster M; Krenning EP; De Jong M
J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
[TBL] [Abstract][Full Text] [Related]
12. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
Breitz HB; Wendt RE; Stabin MS; Shen S; Erwin WD; Rajendran JG; Eary JF; Durack L; Delpassand E; Martin W; Meredith RF
J Nucl Med; 2006 Mar; 47(3):534-42. PubMed ID: 16513624
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG
J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
Kotzerke J; Glatting G; Seitz U; Rentschler M; Neumaier B; Bunjes D; Duncker C; Dohr D; Bergmann L; Reske SN
J Nucl Med; 2000 Mar; 41(3):531-7. PubMed ID: 10716329
[TBL] [Abstract][Full Text] [Related]
15. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
Harrison J
J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
[TBL] [Abstract][Full Text] [Related]
16. Indium-113m-labeled polyfunctional phosphonates as bone-imaging agents.
Subramanian G; McAfee JG; Rosenstreich M; Coco M
J Nucl Med; 1975 Nov; 16(11):1080-4. PubMed ID: 1185269
[TBL] [Abstract][Full Text] [Related]
17. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
Pahlka RB; Sonnad JR
Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
[TBL] [Abstract][Full Text] [Related]
18. S values for radionuclides localized within the skeleton.
Bouchet LG; Bolch WE; Howell RW; Rao DV
J Nucl Med; 2000 Jan; 41(1):189-212. PubMed ID: 10647623
[TBL] [Abstract][Full Text] [Related]
19. Estimates of radiation dose to the embryo from nuclear medicine procedures.
Smith EM; Warner GG
J Nucl Med; 1976 Sep; 17(9):836-9. PubMed ID: 956898
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 131I, 99mTc, and 113mIn for liver scans.
Raikar UR; Ganatra RD
J Nucl Med; 1973 Oct; 14(10):763-4. PubMed ID: 4743585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
